BRNS vs BRO · rev $15.0M vs P/E 30, rev $3.58B
Barinthus Biotherapeutics plc (BRNS) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Barinthus Biotherapeutics plc (BRNS) is a biotechnology company listed on US.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported BRNS revenue for 2024-12-31 was $15.0M. Net income was -$61.2M. Revenue was up 1766.5% from 2023-12-31 to 2024-12-31. BRNS currently screens at market cap $38.2M.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
BRNS currently screens at market cap $38.2M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the BRNS and BRO stock pages for the full models.
Not investment advice.